TherapeuticsMD Inc reports results for the quarter ended in December - Earnings Summary

TherapeuticsMD

07/04/2023 22:26

* TherapeuticsMD Inc  TXMD.OQ  reported quarterly adjusted
earnings of $8.23​​ per share for the quarter ended in December.
The lone analyst forecast for the quarter was for a loss of
$1.11 per share.
    * Revenue fell 93.8% to $1.15 million from a year ago;
analysts
expected $23.80 million. 
    * TherapeuticsMD Inc's reported EPS for the quarter was
$8.23​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TherapeuticsMD Inc shares had fallen by 2.7% this
quarter and
lost 34.7% so far this year.
    * The company reported quarterly net income of $77.7
million.
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 7 at 09:26 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.11          8.23           Beat
 Sep. 30 2022      -0.57          -3.13          Missed
 Jun. 30 2022      -3.04          12.39          Beat
 Mar. 31 2022      -4.00          -5.69          Missed